V-Go Insulin Delivery Device


MannKind Corporation develops and markets V-Go, an all-in-one insulin delivery patch designed to simplify diabetes management by replacing multiple injections with a single, discreet device that mimics natural insulin release and provides on-demand bolus dosing. The company is committed to providing personalized support, training, and resources to help patients and healthcare professionals effectively use V-Go to improve glycemic control and quality of life.

Industries

health-care
medical-device
therapeutics

Nr. of Employees

small (1-50)

V-Go Insulin Delivery Device

MannKind Corporation, 30930 Russell Ranch Road, Suite 300, Westlake Village, CA 91362


Products

Disposable wearable insulin delivery patch (daily)

A single-use, skin-applied patch designed for 24-hour continuous basal insulin delivery with on-demand bolus capability in fixed increments; available in multiple 24-hour total capacity options.

Vial-to-device filling accessory

A supplied mechanical accessory used to transfer U-100 rapid-acting insulin from vials into the wearable patch; instructions specify vial counts required per device dosing option.


Services

One-on-one step-by-step instruction by phone or video from certified trainers covering filling, applying, and using the wearable infusion device.

Telephone and web-based customer support for general questions, training coordination, starter kit requests, and educational material distribution.

Administration of a commercial co-pay savings card with eligibility screening and immediate-download card functionality; information on Medicare Part D and cash-pay options.

Clinician resources including dosing grids, prescription templates, start sheets, and instructions for e-prescribing and pharmacy routing.

Provision of Instructions for Use, Quick Reference Guides, and other regulatory documentation in multiple languages for patients and clinicians.

Expertise Areas

  • Wearable insulin delivery
  • Clinical and real-world evidence generation
  • Patient onboarding and remote training
  • Prescribing and dosing conversion from multiple daily injections
  • Show More (4)

Key Technologies

  • Continuous subcutaneous infusion via wearable patch
  • Mechanical bolus delivery (fixed increment click system)
  • Filling accessory for vial-to-device transfer
  • Medical-grade adhesive wearable materials
  • Show More (3)

News & Updates

Multiple peer-reviewed publications demonstrate V-Go's effectiveness in reducing A1C and insulin requirements in patients with type 2 diabetes.

Studies show significant improvements in glycemic control and reductions in prescribed insulin when switching to V-Go from other insulin regimens.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.